Related Experiment Video
Updated: Sep 18, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Bullous Pemphigoid: Clinical Aspects and Treatments.
Ryan S Q Geng1, R Gary Sibbald
1Ryan S. Q. Geng, MSc, is Medical Student, Temerty School of Medicine, University of Toronto, Toronto, Ontario, Canada. R. Gary Sibbald, MD, MEd, FRCPC, MACP, MAPWCA, JM, is Professor of Medicine and Public Health, Dalla Lana School of Public Health & Division of Dermatology, Department of Medicine, University of Toronto.
Bullous pemphigoid (BP) is a blistering skin disease. This review covers its risk factors, clinical signs, diagnostic methods, and current treatment strategies for healthcare professionals.
Area of Science:
- Dermatology
- Immunodermatology
Background:
- Bullous pemphigoid (BP) is an autoimmune blistering disease.
- This educational activity is designed for healthcare professionals involved in skin and wound care.
Purpose of the Study:
- To review the risk factors and clinical features of bullous pemphigoid (BP).
- To discuss available diagnostic and treatment options for BP.
Main Methods:
- Literature review of risk factors, clinical manifestations, and treatment modalities for BP.
- Synthesis of evidence-based diagnostic and pharmacologic management strategies.
Main Results:
- BP presents with characteristic clinical features and has identifiable risk factors.
- Effective diagnosis relies on specific clinical and laboratory findings.
- Pharmacologic treatments, including corticosteroids and other immunomodulators, are key to managing BP.
Conclusions:
- Understanding BP's risk factors and clinical presentation is crucial for timely diagnosis.
- Evidence-based diagnostic approaches ensure accurate identification of BP.
- Comprehensive management of BP involves tailored pharmacologic strategies for optimal patient outcomes.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

